BMO raises Amgen target price to $442 from $415
AMGN•BMO raised its target price for Amgen to $442 from $415.
Related News
Lifecore Biomedical Q3 revenue misses estimates as CDMO, HA sales decline
LFCR•
Ocugen Q3 revenue beats expectations, net loss narrows
OCGN•
Bernstein raises Amgen target price to $400 from $345
AMGN•
Bruker Q3 revenue tops estimates on US academic unit strength
BRKR•
Arrowhead Pharmaceuticals refinances $400 million loan with Sixth Street
ARWR•